Description

Abecma is a medication used in the treatment of multiple myeloma, a type of blood cancer. It is a CAR T-cell therapy that modifies a patient's T cells to target and destroy cancer cells more effectively.

Interpreter Notes

Interpreters should be aware that Abecma may be referred to in clinical settings as a CAR T-cell therapy. It is important to maintain a formal register and avoid colloquial terms. Be cautious of confusion with other cancer treatments or therapies that have similar names.

Example Sentences

EN: The patient was treated with Abecma to manage their multiple myeloma.

ES: El paciente fue tratado con Abecma para manejar su mieloma múltiple.

Common Interpreter Mistakes

Confusing Abecma with other CAR T-cell therapies; mispronouncing Abecma as 'Abecma' with incorrect emphasis; mixing up multiple myeloma with other types of cancer.